Incorporating external context can significantly enhance the response quality of Large Language Models (LLMs). However, real-world contexts often mix relevant information with disproportionate inappropriate content, posing reliability risks. How do LLMs process and prioritize mixed context? To study this, we introduce the Poisoned Context Testbed, pairing queries with real-world contexts containing relevant and inappropriate content. Inspired by associative learning in animals, we adapt the Rescorla-Wagner (RW) model from neuroscience to quantify how competing contextual signals influence LLM outputs. Our adapted model reveals a consistent behavioral pattern: LLMs exhibit a strong tendency to incorporate information that is less prevalent in the context. This susceptibility is harmful in real-world settings, where small amounts of inappropriate content can substantially degrade response quality. Empirical evaluations on our testbed further confirm this vulnerability. To tackle this, we introduce RW-Steering, a two-stage finetuning-based approach that enables the model to internally identify and ignore inappropriate signals. Unlike prior methods that rely on extensive supervision across diverse context mixtures, RW-Steering generalizes robustly across varying proportions of inappropriate content. Experiments show that our best fine-tuned model improves response quality by 39.8% and reverses the undesirable behavior curve, establishing RW-Steering as a robust, generalizable context engineering solution for improving LLM safety in real-world use.

Sepsis, a life-threatening inflammatory response to infection, causes organ dysfunction, making early detection and optimal management critical. Previous reinforcement learning (RL) approaches to sepsis management rely primarily on structured data, such as lab results or vital signs, and on a dearth of a comprehensive understanding of the patient's condition. In this work, we propose a Multimodal Offline REinforcement learning for Clinical notes Leveraged Enhanced stAte Representation (MORE-CLEAR) framework for sepsis control in intensive care units. MORE-CLEAR employs pre-trained large-scale language models (LLMs) to facilitate the extraction of rich semantic representations from clinical notes, preserving clinical context and improving patient state representation. Gated fusion and cross-modal attention allow dynamic weight adjustment in the context of time and the effective integration of multimodal data. Extensive cross-validation using two public (MIMIC-III and MIMIC-IV) and one private dataset demonstrates that MORE-CLEAR significantly improves estimated survival rate and policy performance compared to single-modal RL approaches. To our knowledge, this is the first to leverage LLM capabilities within a multimodal offline RL for better state representation in medical applications. This approach can potentially expedite the treatment and management of sepsis by enabling reinforcement learning models to propose enhanced actions based on a more comprehensive understanding of patient conditions.

This study employs a robust analytical framework to uncover patterns in survival outcomes among breast cancer patients from diverse racial and geographical backgrounds. This research uses the SEER 2021 dataset to analyze breast cancer survival outcomes to identify and comprehend dissimilarities. Our approach integrates exploratory data analysis (EDA), through this we identify key variables that influence survival rates and employ survival analysis techniques, including the Kaplan-Meier estimator and log-rank test and the advanced modeling Cox Proportional Hazards model to determine how survival rates vary across racial groups and countries. Model validation and interpretation are undertaken to ensure the reliability of our findings, which are documented comprehensively to inform policymakers and healthcare professionals. The outcome of this paper is a detailed version of statistical analysis that not just highlights disparities in breast cancer treatment and care but also serves as a foundational tool for developing targeted interventions to address the inequalities effectively. Through this research, our aim is to contribute to the global efforts to improve breast cancer outcomes and reduce treatment disparities.

Artificial intelligence (AI) has potential to revolutionize the field of oncology by enhancing the precision of cancer diagnosis, optimizing treatment strategies, and personalizing therapies for a variety of cancers. This review examines the limitations of conventional diagnostic techniques and explores the transformative role of AI in diagnosing and treating cancers such as lung, breast, colorectal, liver, stomach, esophageal, cervical, thyroid, prostate, and skin cancers. The primary objective of this paper is to highlight the significant advancements that AI algorithms have brought to oncology within the medical industry. By enabling early cancer detection, improving diagnostic accuracy, and facilitating targeted treatment delivery, AI contributes to substantial improvements in patient outcomes. The integration of AI in medical imaging, genomic analysis, and pathology enhances diagnostic precision and introduces a novel, less invasive approach to cancer screening. This not only boosts the effectiveness of medical facilities but also reduces operational costs. The study delves into the application of AI in radiomics for detailed cancer characterization, predictive analytics for identifying associated risks, and the development of algorithm-driven robots for immediate diagnosis. Furthermore, it investigates the impact of AI on addressing healthcare challenges, particularly in underserved and remote regions. The overarching goal of this platform is to support the development of expert recommendations and to provide universal, efficient diagnostic procedures. By reviewing existing research and clinical studies, this paper underscores the pivotal role of AI in improving the overall cancer care system. It emphasizes how AI-enabled systems can enhance clinical decision-making and expand treatment options, thereby underscoring the importance of AI in advancing precision oncology

Doctors often have a piece of advice for the rest of us: Don't Google it. The search giant tends to be the first stop for people hoping to answer every health-related question: Why is my scab oozing? What is this pink bump on my arm? Search for symptoms, and you might click through to WebMD and other sites that can provide an overwhelming possibility of reasons for what's ailing you. The experience of freaking out about what you find online is so common that researchers have a word for it: cyberchondria.

Santa Cruz Cabralia, Bahia, Brazil – With a loud whir, the drone takes flight. Minutes later, the humming sound gives way to a distinctive rattling as the machine, hovering about 20 metres above the ground, begins unloading its precious cargo and a cocktail of seeds rains down onto the land below. Given time, these seeds will grow into trees and, eventually, it is hoped, a thriving forest will stand where there was once just sparse vegetation. That is what the startup which operates this drone, a large contraption that looks a bit like a Pokemon ball with antennae, hopes. The 54 hectares (133 acres) here which have been badly degraded by agriculture and cattle farming in the Brazilian state of Bahia are just the start.

An accurate model of patient survival time can help in the treatment and care of cancer patients. The common practice of providing survival time estimates based only on population averages for the site and stage of cancer ignores many important individual differences among patients. In this paper, we propose a local regression method for learning patient-specific survival time distribution based on patient attributes such as blood tests and clinical assessments. When tested on a cohort of more than 2000 cancer patients, our method gives survival time predictions that are much more accurate than popular survival analysis models such as the Cox and Aalen regression models. Our results also show that using patient-specific attributes can reduce the prediction error on survival time by as much as 20% when compared to using cancer site and stage only.

Sepsis, a life-threatening condition triggered by the body's exaggerated response to infection, demands urgent intervention to prevent severe complications. Existing machine learning methods for managing sepsis struggle in offline scenarios, exhibiting suboptimal performance with survival rates below 50%. This paper introduces the POSNEGDM -- ``Reinforcement Learning with Positive and Negative Demonstrations for Sequential Decision-Making" framework utilizing an innovative transformer-based model and a feedback reinforcer to replicate expert actions while considering individual patient characteristics. A mortality classifier with 96.7\% accuracy guides treatment decisions towards positive outcomes. The POSNEGDM framework significantly improves patient survival, saving 97.39% of patients, outperforming established machine learning algorithms (Decision Transformer and Behavioral Cloning) with survival rates of 33.4% and 43.5%, respectively. Additionally, ablation studies underscore the critical role of the transformer-based decision maker and the integration of a mortality classifier in enhancing overall survival rates. In summary, our proposed approach presents a promising avenue for enhancing sepsis treatment outcomes, contributing to improved patient care and reduced healthcare costs.

Gastric and oesophageal (OG) cancers are the leading causes of cancer mortality worldwide. In OG cancers, recent studies have showed that PDL1 immune checkpoint inhibitors (ICI) in combination with chemotherapy improves patient survival. However, our understanding of the tumour immune microenvironment in OG cancers remains limited. In this study, we interrogate multiplex immunofluorescence (mIF) images taken from patients with advanced Oesophagogastric Adenocarcinoma (OGA) who received first-line fluoropyrimidine and platinum-based chemotherapy in the PLATFORM trial (NCT02678182) to predict the efficacy of the treatment and to explore the biological basis of patients responding to maintenance durvalumab (PDL1 inhibitor). Our proposed Artificial Intelligence (AI) based marker successfully identified responder from non-responder (p < 0.05) as well as those who could potentially benefit from ICI with statistical significance (p < 0.05) for both progression free and overall survival. Our findings suggest that T cells that express FOXP3 seem to heavily influence the patient treatment response and survival outcome. We also observed that higher levels of CD8+PD1+ cells are consistently linked to poor prognosis for both OS and PFS, regardless of ICI.

Electric quadruped robots used in outdoor exploration are susceptible to leg-related electrical or mechanical failures. Unexpected joint power loss and joint locking can immediately pose a falling threat. Typically, controllers lack the capability to actively sense the condition of their own joints and take proactive actions. Maintaining the original motion patterns could lead to disastrous consequences, as the controller may produce irrational output within a short period of time, further creating the risk of serious physical injuries. This paper presents a hierarchical fault-tolerant control scheme employing a multi-task training architecture capable of actively perceiving and overcoming two types of leg joint faults. The architecture simultaneously trains three joint task policies for health, power loss, and locking scenarios in parallel, introducing a symmetric reflection initialization technique to ensure rapid and stable gait skill transformations. Experiments demonstrate that the control scheme is robust in unexpected scenarios where a single leg experiences concurrent joint faults in two joints. Furthermore, the policy retains the robot's planar mobility, enabling rough velocity tracking. Finally, zero-shot Sim2Real transfer is achieved on the real-world SOLO8 robot, countering both electrical and mechanical failures.